Immunohistopathologic classification, based on the expression/absence of Estrogen Receptor (ER), Progesterone Receptor (PR), or receptor tyrosine kinase HER2, allowed the definition of the major BC subtypes (Figure 1). This evidence concerns the gene NTRK1 and breast cancer.